pevisone 1mg/g + 10mg/g cream
janssen-cilag international nv (0000003494) turnhoutseweg 30, beerse, b-2340 - triamcinolone acetonide; econazole nitrate - cream - triamcinolone acetonide (0000076255) 0.11g; econazole nitrate (0024169026) 1g - combinations
risperdal consta 37.5mg/vial powder & solvent for prolonged release suspenion for injection
janssen-cilag international nv (0000003494) turnhoutseweg, 30, beerse, b-2340 - risperidone - powder & solvent for prolonged release suspenion for injection - 37.5mg/vial - risperidone (0106266062) 37.5mg - risperidone
dehydrobenzperidol/janssen 25mg/10ml vial inj.sol
ΓΙΑΝΣΣΕΝ ΦΑΡΜΑΚΕΥΤΙΚΗ ΑΕΒΕ - droperidol - ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ - 25mg/10ml vial - ΦΑΡΜΑΚΕΥΤΙΚΟ ΠΡΟΪΟΝ
rafipen/janssen sol.iv.inf 1mg/2ml
ΙΦΕΤ ΑΕ 18ο χλμ. Λεωφ. Μαραθώνος,, 153 51 153 51, Παλλήνη Αττικής 210.6603400-6603522 - alfentanil - sol.iv.inf (ΔΙΑΛΥΜΑ ΓΙΑ ΕΝΔΟΦΛΕΒΙΑ ΕΓΧΥΣΗ) - 1mg/2ml - alfentanil - alfentanil
veletri pd.sol.inf 0,5mg/vial
janssen-cilag intern. nv.,belgium turnhoutseweg, 30, b-2340 beerse, - epoprostenol - pd.sol.inf (ΚΟΝΙΣ ΓΙΑ ΔΙΑΛΥΜΑ ΠΡΟΣ ΕΓΧΥΣΗ) - 0,5mg/vial - epoprostenol 0,5mg - epoprostenol
veletri pd.sol.inf 1,5mg/vial
janssen-cilag intern. nv.,belgium turnhoutseweg, 30, b-2340 beerse, - epoprostenol - pd.sol.inf (ΚΟΝΙΣ ΓΙΑ ΔΙΑΛΥΜΑ ΠΡΟΣ ΕΓΧΥΣΗ) - 1,5mg/vial - epoprostenol 1,5mg - epoprostenol
haldol tab 1 μg/tab
janssen-cilag ΦΑΡΜΑΚΕΥΤΙΚΗ ΑΕΒΕ ΛΕΩΦ.ΕΙΡΗΝΗΣ 56,, 151 21 151 21, ΠΕΥΚΗ 210.8090000 - haloperidol - tab (ΔΙΣΚΙΟ) - 1 Μg/tab - haloperidol 1mg - haloperidol
haldol decanoato inj.sol 50 mg/ml
janssen-cilag ΦΑΡΜΑΚΕΥΤΙΚΗ ΑΕΒΕ ΛΕΩΦ.ΕΙΡΗΝΗΣ 56,, 151 21 151 21, ΠΕΥΚΗ 210.8090000 - haloperidol - inj.sol (ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ) - 50 mg/ml - haloperidol 50mg - haloperidol
vermox oral.susp 100mg/5ml
janssen-cilag ΦΑΡΜΑΚΕΥΤΙΚΗ ΑΕΒΕ ΛΕΩΦ.ΕΙΡΗΝΗΣ 56,, 151 21 151 21, ΠΕΥΚΗ 210.8090000 - mebendazole - oral.susp (ΠΟΣΙΜΟ ΕΝΑΙΩΡΗΜΑ) - 100mg/5ml - mebendazole 100mg - mebendazole
invokana
janssen-cilag international nv - καναγλυφλοζίνη - Σακχαρώδης διαβήτης τύπου 2 - Φάρμακα που χρησιμοποιούνται στον διαβήτη - invokana is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise:as monotherapy when metformin is considered inappropriate due to intolerance or contraindicationsin addition to other medicinal products for the treatment of diabetes. for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 και 5.